Founders Fund V Management, LLC
Follow13F filer, CIK 1697733, SAN FRANCISCO, CA
Founders Fund V Management, LLC reported $1,683,986 across 3 holdings for the quarter ended 2024-12-31, in a 13F-HR filed 2025-02-14.
Filed (acceptance time not in the bulk data set), ingested 13F-HR 0001085146-25-001674
- Period
- 2024-12-31
- Reported value
- $1.68M
- Holdings
- 3
- Top 10 weight
- 100%
- New
- 0
- Sold out
- 1
Largest buys vs the previous quarter
None.
Largest sells vs the previous quarter
| Security | Shares change | Approx. value |
|---|---|---|
| NTBLQexited | -117,924 | -$50.7K |
Ranked by the share change valued at this quarter's implied price (value over shares in the 13F). A position sold out is valued at the previous quarter's price, its last report.
Holdings, Q4 2024
Share positions as resolved from 13F-HR 0001085146-25-001674, largest first. % of portfolio is the value over $1,683,986, the sum of the share positions whose value is usable for ratios (method).
| Security | History | Shares | Value | % of portfolio | Change | Latest event | Timeline |
|---|---|---|---|---|---|---|---|
| RGTIRIGETTI COMPUTING INC | 88,621 | $1.35M | 80.31% | 0 | Timeline | ||
| CYCLO THERAPEUTICS INCCYCLO THERAPEUTICS INC | 480,708 | $284K | 16.84% | 0 | |||
| UNITY BIOTECHNOLOGY INC COM…UNITY BIOTECHNOLOGY INC COM NEW | 49,172 | $48K | 2.85% | 0 |
Sold out in Q4 2024
Positions in the previous quarter's report that this quarter's report no longer lists.
| Security | Shares before | Value before | Type |
|---|---|---|---|
| NTBLQNOTABLE LABS LTD ORD SHS | 117,924 | $50.7K | shares |
How Q4 2024 was built
Available 13F filings of this filer for the quarter and their roles: the base report is the latest original or restatement, NEW HOLDINGS amendments filed after it are added (method).
| Filing | Role | Amendment | Filed | Accepted | Ingested |
|---|---|---|---|---|---|
| 13F-HR 0001085146-25-001674 | base | 2025-02-14 | acceptance time not in the bulk data set |